| |
| |
|
| Insider
Information: |
Mckinnell Henry A |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
3,072,534 |
|
|
Indirect Shares
|
253,582 |
|
|
| Direct
Value |
$103,699,663 |
|
|
|
Indirect Value
|
$7,102,832 |
|
|
| Total
Shares |
3,326,116 |
|
|
| Total
Value |
$110,802,494 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Moodys Corp |
MCO |
Director |
2021-03-18 |
89,488 |
2003-09-25 |
0 |
Premium* |
|
|
Pfizer Inc |
PFE |
Director |
2007-02-28 |
2,134,851 |
2007-02-28 |
253,582 |
Premium* |
|
|
Exxon Mobil Corp |
XOM |
Director |
2007-01-03 |
36,400 |
2004-05-26 |
0 |
Premium* |
|
|
Angiotech Pharmaceuticals Inc(USA) |
ANPIQ |
Director |
2008-05-12 |
50,000 |
|
0 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
CEO and Chairman of th... |
2013-10-24 |
0 |
|
0 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
Director |
2019-01-02 |
689,046 |
2016-08-22 |
0 |
Premium* |
|
|
Chemocentryx, Inc. |
CCXI |
Director |
2022-05-20 |
72,749 |
2016-11-03 |
0 |
Premium* |
|
|
Federal Street Acquisition Corp |
FSAC |
Director |
2019-01-04 |
0 |
2019-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANPIQ |
Angiotech Pharmaceuticals... |
Director |
– • – |
2008-05-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2011-01-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2003-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,250 |
1,097,198 |
|
- |
|
| XOM |
Exxon Mobil Corp |
Director |
– • – |
2004-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,400 |
22,800 |
|
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2004-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,389 |
9,115 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2004-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
75,060 |
1,224,147 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2004-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
125,100 |
1,353,948 |
|
- |
|
| XOM |
Exxon Mobil Corp |
Director |
– • – |
2004-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,600 |
24,400 |
|
- |
|
| XOM |
Exxon Mobil Corp |
Director |
– • – |
2005-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
28,400 |
|
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2005-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,199 |
10,329 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2005-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
220,800 |
1,558,472 |
|
- |
|
| PFE |
Pfizer Inc |
officerTitle |
• • – |
2005-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,400 |
1,508,996 |
|
- |
|
| XOM |
Exxon Mobil Corp |
officerTitle |
– • – |
2006-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
32,400 |
|
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2006-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,585 |
22,280 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman and CEO |
• • – |
2006-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
299,180 |
1,846,017 |
|
- |
|
| PFE |
Pfizer Inc |
Chairman of the Board |
– • – |
2006-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,030 |
1,944,258 |
0 |
- |
|
| PFE |
Pfizer Inc |
Chairman of the Board |
– • – |
2006-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,330 |
1,933,928 |
0 |
- |
|
| XOM |
Exxon Mobil Corp |
Director |
– • – |
2007-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
36,400 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2007-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,582 |
23,912 |
0 |
- |
|
| PFE |
Pfizer Inc |
Director |
– • – |
2007-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
198,000 |
2,170,160 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2008-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,021 |
33,373 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2009-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,533 |
44,106 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2010-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,295 |
58,737 |
0 |
- |
|
| MCO |
Moodys Corp |
Director |
– • – |
2011-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,665 |
85,441 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
15,000 |
0 |
- |
|
148 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
